+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Construction of a Novel DNA Vaccine Candidate encoding LmSTI1-PpSP42 Fusion Protein from Leishmania major and Phlebotomus papatasi against Cutaneous Leishmaniasis



Construction of a Novel DNA Vaccine Candidate encoding LmSTI1-PpSP42 Fusion Protein from Leishmania major and Phlebotomus papatasi against Cutaneous Leishmaniasis



Reports of Biochemistry and Molecular Biology 7(1): 67-75



Cutaneous leishmaniasis (CL) is a serious public health problem in many tropical countries. The infection is caused by a protozoan parasite of Leishmania genus transmitted by Phlebotominae sandflies. In the present study, we constructed a eukaryotic expression vector to produce a fusion protein containing LmSTI1 from Leishmania major (L. major) and PpSP42 from Phlebotomus papatasi (Ph. papatasi). In future studies we will test this construct as a DNA vaccine against zoonotic CL. The nucleotide sequences encoding the LmSTI1 protein and a fragment encoding 79% of PpSP42 were amplified using L. major and Ph. papatasi genomic DNA, respectively. The amplicons were cloned into the pcDNA3.1(+) eukaryotic expression vector. The recombinant plasmid pcDNA-LmSTI1Pp42 was propagated in Escherichia coli (E. coli) and used to transfect HEK-293T cells. The expressed fusion protein was analyzed by Western blotting using anti-LmSTI1 mouse serum. Sequences encoding LmSTI1 and partial PpSP42 were cloned into pcDNA3.1(+). Production of the recombinant LmSTI1Pp42 fusion protein was confirmed by Western blotting. An LmSTI1Pp42 fusion protein was expressed HEK-293T cells. This construct may be an effective DNA vaccine against CL.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 065738893

Download citation: RISBibTeXText

PMID: 30324120


Related references

Detection, identification and molecular typing of Leishmania major in Phlebotomus papatasi from a focus of zoonotic cutaneous leishmaniasis in central of Iran. Experimental Parasitology 124(2): 232-237, 2010

Detection of Leishmania major DNA within wild caught Phlebotomus papatasi and species composition of sand flies in endemic focus of cutaneous leishmaniasis, in western Iran. Journal of Parasitic Diseases 40(1): 69-74, 2016

Anthroponotic cutaneous leishmaniasis in Kabul, Afghanistan: the low susceptibility of Phlebotomus papatasi to Leishmania tropica. Transactions of the Royal Society of Tropical Medicine and Hygiene 88(2): 252-253, 1994

First detection of Leishmania infantum DNA in wild caught Phlebotomus papatasi in endemic focus of cutaneous leishmaniasis, South of Iran. Asian Pacific Journal of Tropical Biomedicine 3(10): 825-829, 2013

Insecticide susceptibility status of Phlebotomus (Paraphlebotomus) sergenti and Phlebotomus (Phlebotomus) papatasi in endemic foci of cutaneous leishmaniasis in Morocco. Parasites and Vectors 5: 51, 2012

Colonization and biology of Phlebotomus papatasi, the main vector of cutaneous leishmaniasis due to Leshmania major. 2007

Attachment of Leishmania major and Leishmania infantum in the midgut of their respective sand fly vectors Phlebotomus papatasi and Phlebotomus langeroni. Journal Of The Egyptian Society Of Parasitology: 3, 833-842, 2008

Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice. Infection and Immunity 70(6): 2828-2836, 2002

Attachment of Leishmania major and Leishmania infantum in the midgut of their respective sand fly vectors Phlebotomus papatasi and Phlebotomus langeroni (Diptera: Psychodidae). Journal of the Egyptian Society of Parasitology 38(3): 833-842, 2008

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major. Vaccine 19(25/26): 3369-3375, 2001

Epidemiology of cutaneous leishmaniasis in iran ii natural leptomonad infection of sand flies in the meshed and lotfabad areas iran human phlebotomus sergenti phlebotomus papatasi phlebotomus caucasicus phlebotomus mongolensis sergentomyia clydei. Bulletin de la Societe de Pathologie Exotique 60(6): 514-518, 1968

Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice. Vaccine 37(24): 3221-3228, 2019

Development of Leishmania major in the phlebotomine sandflies, Phlebotomus papatasi (Scopoli) and Phlebotomus langeroni (Nitzulescu). Annales de Parasitologie Humaine et Comparee 63(2): 146-151, 1988

Cloning and Constructing a Plasmid Encoding Leishmania Eukaryotic Initiation Factor Gene of Leishmania major Fused with Green Fluorescent Protein Gene as a Vaccine Candidate. West Indian Medical Journal 65(2): 256-259, 2015

Phlebotomus papatasi exposure cross-protects mice against Leishmania major co-inoculated with Phlebotomus duboscqi salivary gland homogenate. Acta Tropica 144: 9-18, 2015